Close Menu

Thanks to Framingham

The town of Framingham, Mass., should get a "global standing ovation" for what it has contributed to our knowledge of heart disease, says healthcare consultant Brian McGowan at The Scientist's opinion column. The 1948 Framingham Heart Study, the follow-up 1971 FHS Offspring study, and the 2002 third-generation study are observational, and all data is collected in a huge database that's shared among researchers and physicians.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.